D
Bristol-Myers Squibb Company BMY
$59.01 -$1.27-2.11%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income 72.00M 1.21B 1.68B -11.91B 1.76B
Total Depreciation and Amortization 1.85B 2.63B 2.62B 2.47B 2.45B
Total Amortization of Deferred Charges -- -- -28.00M 28.00M --
Total Other Non-Cash Items 1.24B 41.00M 421.00M 12.05B -814.00M
Change in Net Operating Assets 1.28B 1.71B -2.37B 198.00M 855.00M
Cash from Operations 4.44B 5.59B 2.33B 2.83B 4.25B
Capital Expenditure -378.00M -324.00M -262.00M -284.00M -330.00M
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -47.00M -348.00M -1.37B -20.05B -581.00M
Divestitures 333.00M 255.00M 270.00M 241.00M 241.00M
Other Investing Activities -104.00M 198.00M 46.00M 478.00M -676.00M
Cash from Investing -196.00M -219.00M -1.32B -19.62B -1.35B
Total Debt Issued -405.00M 95.00M 326.00M 15.95B 4.22B
Total Debt Repaid 0.00 -2.75B -3.13B -- -2.12B
Issuance of Common Stock -- -- -- -- 25.00M
Repurchase of Common Stock -- -- -- -- 0.00
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -1.22B -1.22B -1.22B -1.21B -1.16B
Other Financing Activities -19.00M 16.00M -6.00M -97.00M --
Cash from Financing -1.64B -3.85B -4.02B 14.64B 967.00M
Foreign Exchange rate Adjustments -147.00M 77.00M -22.00M -45.00M 78.00M
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 2.45B 1.60B -3.04B -2.19B 3.95B
Weiss Ratings